Cargando…

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes

Detalles Bibliográficos
Autores principales:	Gandaglia, Giorgio, Pellegrino, Antony, Montorsi, Francesco, Briganti, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Open to Debate: For
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844839/ https://www.ncbi.nlm.nih.gov/pubmed/35199040 http://dx.doi.org/10.1016/j.euros.2021.06.016

Ejemplares similares

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

TREXIT Is Now: Should We Abandon the Transrectal Route for Prostate Biopsy? Yes
por: Grummet, Jeremy P., et al.
Publicado: (2021)

There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022)

Cytoreductive Nephrectomy: Still Necessary in 2021
por: Méjean, Arnaud, et al.
Publicado: (2022)

High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key
por: Terlizzi, Mario, et al.
Publicado: (2022)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021)

Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
por: Scuderi, Simone, et al.
Publicado: (2023)

Radiotherapy is the Preferred Primary Tumor Treatment in Oligometastatic Prostate Cancer
por: van Moorselaar, R. Jeroen A., et al.
Publicado: (2022)

How To Manage T3b Prostate Cancer in the Contemporary Era: Is Radiotherapy the Standard of Care?
por: Achard, Vérane, et al.
Publicado: (2023)

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
por: Bandini, Marco, et al.
Publicado: (2017)

Cytoreductive Nephrectomy in 2021: Obsolete but Necessary
por: Capitanio, Umberto, et al.
Publicado: (2021)

Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer
por: Gandaglia, Giorgio, et al.
Publicado: (2023)

Are the days of closed pleural biopsy over? Yes
por: Patel, Dharmesh
Publicado: (2015)

How To Manage T3b Prostate Cancer in the Contemporary Era: Referee Position
por: Bossi, Alberto, et al.
Publicado: (2023)

How To Deal with Renal Cell Carcinoma Tumors >7 cm: The Role of Nephron-sparing Surgery
por: Minervini, Andrea, et al.
Publicado: (2021)

Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?—a narrative review
por: Pellegrino, Antony, et al.
Publicado: (2022)

Is the Choice Between Clips and No Clips or Cautery and No Cautery Still a Dilemma in Robot-assisted Radical Prostatectomy?
por: Artibani, Walter, et al.
Publicado: (2022)

Accuracy Versus Impact: The Referee Verdict on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Staging of Prostate Cancer
por: O'Brien, Jonathan, et al.
Publicado: (2021)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer: Con
por: van der Poel, Henk
Publicado: (2021)

Primary Tumor Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Knipper, Sophie, et al.
Publicado: (2022)

Primary Tumour Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Ting, Francis, et al.
Publicado: (2022)

How To Manage T3b Prostate Cancer in the Contemporary Era: The Benefits of Surgery
por: Peyrottes, Arthur, et al.
Publicado: (2023)

TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—No
por: Olivier, Jonathan, et al.
Publicado: (2021)

TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—Referee
por: van den Bergh, Roderick C.N., et al.
Publicado: (2021)

Which Is the Best Laser for Lithotripsy? Holmium Laser
por: Kim, Hyung Joon, et al.
Publicado: (2022)

Which Is the Best Laser for Lithotripsy? Thulium Fiber Laser
por: Traxer, Olivier, et al.
Publicado: (2022)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Pro
por: Campbell, Steven C., et al.
Publicado: (2022)

Nerve-sparing Techniques During Robot-assisted Radical Prostatectomy: Clips
por: Zhu, Alec, et al.
Publicado: (2022)

Long Live Holmium!
por: Socarrás, Moisés Rodriguez, et al.
Publicado: (2022)

Thulium Fiber Laser: Bringing Lasers to a Whole New Level
por: Enikeev, Dmitry, et al.
Publicado: (2022)

Open science versus commercialization: a modern research conflict?
por: Caulfield, Timothy, et al.
Publicado: (2012)

An ethics safe harbor for international genomics research?
por: Dove, Edward S, et al.
Publicado: (2013)

Harvard Personal Genome Project: lessons from participatory public research
por: Ball, Madeleine P, et al.
Publicado: (2014)

Disentangling Public Participation In Science and Biomedicine
por: Kelty, Christopher, et al.
Publicado: (2014)

Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis(® )compared to Genentech's Herceptin(®)
por: Baldwin, A Lane, et al.
Publicado: (2013)

Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy
por: Sayres, Lauren C, et al.
Publicado: (2012)

Conservative Treatment for Upper Urinary Tract Urothelial Carcinoma
por: Traxer, Olivier, et al.
Publicado: (2021)

How to Deal with Renal Cell Carcinoma >7 cm: Radical Surgery
por: Grimm, Marc-Oliver, et al.
Publicado: (2021)

Percutaneous Nephrolithotomy: Which Position? Supine Position!
por: Giusti, Guido, et al.
Publicado: (2021)

Percutaneous Nephrolithotomy for Stone Disease: Which Position? Prone Position!
por: Liatsikos, Evangelos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m0dg6bqrnt9bt04krehdkja4df